Molina Healthcare, Inc. MOH
We take great care to ensure that the data presented and summarized in this overview for MOLINA HEALTHCARE, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MOH
View all-
Vanguard Group Inc Valley Forge, PA6.58MShares$2.07 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY5.19MShares$1.63 Billion0.04% of portfolio
-
Capital World Investors Los Angeles, CA5.11MShares$1.61 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA3.49MShares$1.1 Billion0.22% of portfolio
-
Wellington Management Group LLP Boston, MA2.63MShares$829 Million0.14% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.62MShares$825 Million0.09% of portfolio
-
State Street Corp Boston, MA2.53MShares$798 Million0.03% of portfolio
-
Capital International Investors Los Angeles, CA1.58MShares$498 Million0.09% of portfolio
-
Geode Capital Management, LLC Boston, MA1.44MShares$452 Million0.03% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.37MShares$431 Million0.25% of portfolio
Latest Institutional Activity in MOH
Top Purchases
Top Sells
About MOH
Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. As of December 31, 2021, the company served the company served approximately 5.2 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 18 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Insider Transactions at MOH
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 03
2025
|
Steven J Orlando Director |
SELL
Open market or private sale
|
Indirect |
1,000
-5.44%
|
$301,000
$301.33 P/Share
|
Mar 01
2025
|
Maurice Hebert Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,694
+10.59%
|
$792,036
$294.62 P/Share
|
Mar 01
2025
|
Maurice Hebert Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
959
-4.34%
|
$288,659
$301.12 P/Share
|
Mar 01
2025
|
Debra Bacon EVP, Medicaid |
BUY
Grant, award, or other acquisition
|
Direct |
9,659
+26.63%
|
$2,839,746
$294.62 P/Share
|
Mar 01
2025
|
Debra Bacon EVP, Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
2,701
-11.03%
|
$813,001
$301.12 P/Share
|
Mar 01
2025
|
Jeff D. Barlow Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,741
+7.94%
|
$3,745,854
$294.62 P/Share
|
Mar 01
2025
|
Jeff D. Barlow Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,072
-4.18%
|
$1,827,672
$301.12 P/Share
|
Mar 01
2025
|
Joseph M Zubretsky President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
65,487
+7.68%
|
$19,253,178
$294.62 P/Share
|
Mar 01
2025
|
Joseph M Zubretsky President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
29,029
-3.76%
|
$8,737,729
$301.12 P/Share
|
Mar 01
2025
|
James Woys Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,564
+10.87%
|
$4,575,816
$294.62 P/Share
|
Mar 01
2025
|
James Woys Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,000
-4.04%
|
$1,505,000
$301.12 P/Share
|
Mar 01
2025
|
Mark Lowell Keim Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,425
+14.14%
|
$5,710,950
$294.62 P/Share
|
Mar 01
2025
|
Mark Lowell Keim Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,533
-6.66%
|
$2,267,433
$301.12 P/Share
|
Jan 01
2025
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
189
+1.02%
|
$54,999
$291.05 P/Share
|
Jan 01
2025
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
189
+1.2%
|
$54,999
$291.05 P/Share
|
Jan 01
2025
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
189
+6.34%
|
$54,999
$291.05 P/Share
|
Jan 01
2025
|
Debra Bacon EVP, Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
450
-6.9%
|
$130,950
$291.05 P/Share
|
Jan 01
2025
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
189
+2.9%
|
$54,999
$291.05 P/Share
|
Jan 01
2025
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
189
+4.28%
|
$54,999
$291.05 P/Share
|
Jan 01
2025
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
189
+1.58%
|
$54,999
$291.05 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 131K shares |
---|
Payment of exercise price or tax liability | 51.9K shares |
---|---|
Open market or private sale | 18.1K shares |